Laura Koth is a Respiratory physician affiliated with University of California, San Francisco. OpenAlex indexes 107 publications with 9,295 citations (h-index 35); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
400 Parnassus Ave
San Francisco, CA 941432202
Telephone
415-353-2961Registry record last updated 11 Sept 2008.
Clinical trials
- Risk Indicators of Sarcoidosis Evolution-Unified Protocol
Sponsor: University of California, San Francisco
- Use of CXCL9 as a Biomarker of Acthar Efficacy
Sponsor: University of California, San Francisco
- Ancillary T Cell Based Studies in SPIROMICS
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- ANI Pharmaceuticals, Inc.Program year20242 payments
- Genentech, Inc.Program year20221 payment$17,485openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
6 NIH research awards on record, funded 2003–2025 per NIH RePORTER. The latest:
- Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis
University of California, San Francisco
FY2025$994,512R01HL157533 - Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis
University of California, San Francisco
FY2025$128,372R01HL157533 - Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis
University of California, San Francisco
FY2024$974,622R01HL157533
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Discovery of Two Novel Immunoepitopes and Development of a Peptide-based Sarcoidosis Immunoassay
American Journal of Respiratory and Critical Care Medicine
2024 - Genome-wide association study identifies multiple HLA loci for sarcoidosis susceptibility
Human Molecular Genetics
2023 - Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019
Annals of the American Thoracic Society
2023 - Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis
European Respiratory Journal
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”